Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

Robert L. Coleman, Linda Duska, Pedro T. Ramírez, John V. Heymach, Aparna A. Kamat, Susan C. Modesitt, Kathleen M. Schmeler, Revathy B. Iyer, Michael Garcia, Debbie Miller,

The Lancet Oncology · 2011 · 96 citations · 42 references

DOIFull text

Open access

Concepts

References

42